Relationship Between Serum Vitamin D Levels and Postherpetic Neuralgia.

Launched by FENG GAO · Jan 22, 2024

Keywords

ClinConnect Summary

This clinical trial is looking into how levels of vitamin D in the blood might affect patients with postherpetic neuralgia (PHN), which is pain that can occur after a shingles infection. Researchers want to understand if low vitamin D levels are linked to more severe pain, how well treatments work, and the overall health outlook for patients. They are also examining how inflammation and immune factors might play a role in these patients' experiences.

To participate in this study, individuals need to be at least 18 years old and have been diagnosed with herpetic neuralgia for no more than three months. The study is open to all genders. However, people with serious spinal issues, a history of certain autoimmune diseases, mental health disorders, or those who are pregnant or breastfeeding cannot take part. Participants can expect to answer questions and complete assessments about their condition throughout the trial. This research may help improve understanding and treatment of postherpetic neuralgia in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥18 years.
• • The patient was diagnosed with herpetic neuralgia and the course of disease was ≤3 months.
• • Can cooperate with the completion of inquiry and scale evaluation.
• Exclusion Criteria:
• • Severe spinal disease (fracture, malignancy, acute or chronic infection) confirmed by previous spinal surgery or imaging.
• • Previous history of head trauma.
• • Have autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis, leucothrombocytopenia).
• • Suffering from mental disorders, intellectual disability, epilepsy and other diseases.
• • A history of substance abuse, drug abuse or alcohol abuse.
• • Pregnant or breastfeeding women.
• • And recent participation in other clinical studies.